U.S. Catheter Securement Device Market Size, Share & Forecast 2026–2032

ID: MR-11658 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Catheter Securement Devices
  • ✓Market Size 2024: USD 412 million
  • ✓Market Size 2032: USD 647 million
  • ✓CAGR: 5.8%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Sutureless Devices Gaining Share: 3M's Tegaderm CHG dressing and Becton Dickinson's Statlock line dominate U.S. hospital securement, but sutureless devices from Venetec International are capturing home infusion PICC volume. Sutureless products now account for over 30 percent of new home infusion securement orders, according to distributor shipment data.
FINDING 02
Infection Mandates Overstate Demand: The assumption that CLABSI reduction mandates automatically expand securement device volumes is overstated. CMS penalties are pushing hospitals toward chlorhexidine dressings that bundle securement, shrinking standalone device revenue across acute care budgets through 2028.
ANALYST RECOMMENDATION

Analyst Recommendation — Enter Through Home Infusion Now: Medical device suppliers should secure home infusion pharmacy contracts with Option Care Health before the 2026 Medicare reimbursement cycle closes. Lead with sutureless, chlorhexidine-coated designs carrying 510(k) clearance, because home infusion holds the fastest PICC volume growth nationally.

Catheter Securement Devices in the U.S.: Market Overview

The U.S. catheter securement device market is valued at USD 412 million in 2024 and represents roughly 38 percent of global securement revenue, making it the largest single national market. Demand is anchored in acute care, where more than 5,000 U.S. hospitals insert central venous and peripherally inserted catheters daily. Unlike Europe, where national tenders dominate, U.S. purchasing flows through group purchasing organizations such as Vizient and Premier, which shape pricing across thousands of facilities.

Structurally, the market splits between hospital-grade sutured and sutureless devices and outpatient adhesive products. Becton Dickinson's Statlock line and Venetec's SecurAcath remain established reference designs, while 3M's Tegaderm CHG dressing has pushed into securement through integrated dressing-plus-anchor designs. Most devices are Class II products cleared through the FDA 510(k) pathway, which keeps entry moderate but requires clinical equivalence data for each new variant. Hospitals rarely switch once a standard is embedded in nursing protocols.

Growth Drivers in U.S. Catheter Securement

Three country-specific forces lift demand. First, CMS Hospital-Acquired Condition reduction programs penalize catheter-related bloodstream infections, prompting facilities to adopt securement that reduces catheter movement and dressing disruption. Second, the U.S. population aged 65 and over reached roughly 58 million in 2022 according to Census Bureau estimates, driving longer-term PICC and midline use. Third, Medicare coverage of home infusion therapy under Part B sustains outpatient catheter volumes.

Home infusion has become the fastest-growing use case. The Medicare Home Infusion Therapy services benefit, effective January 2021, created a reimbursable professional fee for nursing visits, which pushed infusion pharmacies such as Option Care Health to expand PICC and midline volumes. Securement is a required element of each home line, and every line change or dressing replacement consumes securement inventory, giving the segment repeat purchase economics that acute care lacks.

Market Restraints and Entry Barriers in the U.S.

The Federal Food, Drug, and Cosmetic Act requires a 510(k) premarket notification for each new securement variant, and FDA review times often extend past 90 days when predicate comparisons are contested. The revised Quality Management System Regulation under 21 CFR Part 820, aligned with ISO 13485 from February 2026, adds documentation burden for small suppliers. Group purchasing organizations negotiate multi-year contracts that lock in incumbents, so new entrants typically accept lower initial margins.

Pricing pressure compounds regulatory friction. Hospitals treat securement as commodity consumables, so per-unit prices for sutureless devices have fallen under value analysis committee review, which evaluates products against nursing time and infection data. Distribution is also fragmented: Cardinal Health and Medline control most hospital med-surg distribution, meaning manufacturers without their own sales forces face delayed access to end-user accounts.

Near-Term Entry Opportunities in U.S. Catheter Securement

The clearest near-term opportunity is home infusion PICC securement, an addressable pool estimated at USD 95 million in 2024 across roughly 1,100 licensed infusion pharmacies. Chlorhexidine-impregnated, sutureless devices that combine securement and antimicrobial dressing functions command premiums of 20 to 30 percent over standard adhesive anchors. Ambulatory infusion centers represent a second channel with lower group purchasing exposure.

Ambulatory surgery centers and dialysis facilities offer a second pathway with weaker GPO lock-in. Outpatient surgical volume in the United States exceeds 30 million procedures annually, and independent ASCs typically buy through regional distributors rather than national contracts. Veterans Affairs medical centers, procuring through the Federal Supply Schedule, present a third channel with fixed multi-year pricing that rewards suppliers able to meet VA sourcing requirements.

Market at a Glance

MetricU.S. Catheter Securement Devices
Market Size 2024USD 412 million
Market Size 2032USD 647 million
Growth Rate (CAGR)5.8%
Most Critical Decision FactorGPO contract access and 510(k) clearance timelines
Largest RegionSouth Region
Competitive StructureConcentrated among top med-surg suppliers, fragmented specialists

Leading Market Participants

  • Becton Dickinson
  • ICU Medical
  • Teleflex
  • Medline Industries
  • Cardinal Health
  • B. Braun Medical
  • Avanos Medical
  • 3M
  • Venetec International
  • Medtronic

Regulatory and Policy Environment in the U.S.

FDA oversight of catheter securement devices runs through the Center for Devices and Radiological Health under the Federal Food, Drug, and Cosmetic Act. Most products require 510(k) clearance, while the Quality Management System Regulation under 21 CFR Part 820 transitions to ISO 13485 alignment effective February 2, 2026, requiring manufacturers to update design controls and supplier audits within that window. Biocompatibility testing follows ISO 10993 standards, and Medical Device User Fee Amendments fee schedules apply to each submission.

Reimbursement and infection policy shape purchasing. The CMS Hospital-Acquired Condition Reduction Program penalizes hospitals with elevated CLABSI rates, and reporting flows through the CDC National Healthcare Safety Network. The Medicare Physician Fee Schedule and the Part B home infusion benefit, administered by CMS, set compensation for nursing visits rather than devices. Compliance preparation for the 2026 QMSR transition must be completed before the next CMS rule cycle begins.

Outlook for U.S. Catheter Securement Devices to 2032

By 2032 the U.S. market is forecast to reach USD 647 million at a 5.8 percent CAGR from the 2025 base year. Growth will concentrate in home infusion and ambulatory settings, where sutureless and antimicrobial designs will represent a majority of unit volume, displacing sutured hospital standards. Acute-care revenue will grow more slowly as dressing-integrated products absorb standalone securement spend.

Consolidation will reshape supply. Larger med-surg suppliers such as Medline and Cardinal Health will continue acquiring mid-sized securement specialists and integrating securement into bundled procedure kits. Manufacturers that maintain ISO 13485 certified supply and rapid 510(k) turnaround will hold the advantage, while single-product entrants without distribution access will face margin compression through 2032.

Frequently Asked Questions

Most products are Class II devices requiring FDA 510(k) clearance, which typically takes several months. Manufacturers should plan for predicate comparison and biocompatibility testing under ISO 10993.
Vizient and Premier negotiate multi-year contracts that many hospitals adopt as standard. New suppliers usually need a clinical value case to win value analysis committee approval.
Home infusion PICC securement offers repeat purchasing and less GPO exposure. Infusion pharmacies buy through direct accounts and regional distributors.
Securement devices are typically bundled into hospital DRG payments rather than separately reimbursed. Home infusion reimbursement covers nursing visits, indirectly supporting device volumes.
The Quality Management System Regulation aligned with ISO 13485 takes effect February 2, 2026. Manufacturers must update design controls and supplier audit procedures before that date.

Market Segmentation

By Product Type
  • Sutured Securement Devices
  • Sutureless Adhesive Securement Devices
  • Chlorhexidine-Impregnated Securement Dressings
  • Integrated Securement Dressings
  • Bridge Securement Devices
By End User
  • Acute Care Hospitals
  • Home Infusion Pharmacies
  • Ambulatory Surgery Centers
  • Dialysis Facilities
  • Veterans Affairs Medical Centers
By Distribution Channel
  • Group Purchasing Organizations
  • Med-Surg Distributors
  • Direct Sales Force
  • Federal Supply Schedule
  • Online Medical Supply Platforms

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 United States Catheter Securement Devices - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Product Type Insights
4.1 Sutured Securement Devices
4.2 Sutureless Adhesive Securement Devices
4.3 Chlorhexidine-Impregnated Securement Dressings
4.4 Integrated Securement Dressings
4.5 Others
Chapter 05 End User Insights
5.1 Acute Care Hospitals
5.2 Home Infusion Pharmacies
5.3 Ambulatory Surgery Centers
5.4 Dialysis Facilities
5.5 Others
Chapter 06 Distribution Channel Insights
6.1 Group Purchasing Organizations
6.2 Med-Surg Distributors
6.3 Direct Sales Force
6.4 Federal Supply Schedule
6.5 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 Becton Dickinson
7.2.2 ICU Medical
7.2.3 Teleflex
7.2.4 Medline Industries
7.2.5 Cardinal Health
7.2.6 B. Braun Medical
7.2.7 Avanos Medical
7.2.8 3M
7.2.9 Venetec International
7.2.10 Medtronic
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.